| Stem Cell Therapy for Early Alzheimer's Disease (NCT06775964) | Paul E Schulz | 2026-03-11 |
| A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis (NCT07351968) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-10 |
| Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function (NCT07342881) | Aligos Therapeutics | 2026-03-10 |
| A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults (NCT07456059) | Edgewise Therapeutics, Inc. | 2026-03-10 |
| Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years (NCT07428759) | GlaxoSmithKline | 2026-03-10 |
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease (NCT07224490) | Stephanie B. Seminara, MD | 2026-03-10 |
| cfMSC Stem Cell Therapy Targeting COPD (NCT07477600) | Shenzhen Geno-Immune Medical Institute | 2026-03-10 |
| Mass Balance Study of [14C] D-2570 (NCT07411742) | InventisBio Co., Ltd | 2026-03-10 |
| Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety (NCT07453862) | Beijing Friendship Hospital | 2026-03-10 |
| A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) (NCT07408232) | Octant, Inc. | 2026-03-10 |
| Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors (NCT07631793) | Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | 2026-03-10 |
| A Study of BGM-2121 in Patients With Advanced Solid Tumors (NCT07346846) | BioGate Precision Medicine Corp. | 2026-03-10 |
| Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia (NCT07392814) | Nantes University Hospital | 2026-03-10 |
| A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (NCT07061574) | City of Hope Medical Center | 2026-03-10 |
| A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer. (NCT07462468) | WestVac Biopharma Co., Ltd. | 2026-03-10 |
| Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets (NCT07486453) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2026-03-09 |
| Drug Interaction and Food Effect Study of CS0159 (NCT07429331) | Cascade Pharmaceuticals, Inc | 2026-03-09 |
| Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants (NCT07494214) | University Hospital, Basel, Switzerland | 2026-03-09 |
| Essential Amino Acids and Parkinsons Disease (NCT06604065) | University of Arkansas | 2026-03-09 |
| A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (NCT07464314) | GlaxoSmithKline | 2026-03-09 |
| Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine (NCT07418229) | Sinovac Biotech Co., Ltd | 2026-03-09 |
| Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) (NCT07389278) | Sabine Mueller, MD, PhD | 2026-03-09 |
| A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors (NCT07584226) | Relay Therapeutics, Inc. | 2026-03-09 |
| First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy (NCT06439914) | Nerissa T. Viola | 2026-03-09 |
| A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects (NCT07334496) | Gan & Lee Pharmaceuticals. | 2026-03-09 |
| A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) (NCT07190833) | Bionoxx Inc. | 2026-03-09 |
| Evaluation of the Outcome of Fecal Microbiota Transplantation (NCT07454408) | Air Force Military Medical University, China | 2026-03-07 |
| Morning-Evening Specific Longevity Food Supplement (NCT07416396) | University of Primorska | 2026-03-07 |
| Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury (NCT07635277) | West China Hospital | 2026-03-07 |
| A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects (NCT07264335) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-07 |
| Sex-Speciffic Longevity Food Supplements (NCT07404449) | University of Primorska | 2026-03-07 |
| Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets (NCT07691203) | Humanis Saglık Anonim Sirketi | 2026-03-07 |
| CAR-NK Therapy for Cardiac Amyloidosis (NCT07504289) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-07 |
| A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects (NCT07594847) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-03-07 |
| A Trial of SHR-2173 in Healthy Volunteers (NCT07390747) | Atridia Pty Ltd. | 2026-03-06 |
| A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA). (NCT07234773) | Kali Therapeutics, Inc. | 2026-03-06 |
| Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) (NCT07223983) | Yale University | 2026-03-06 |
| A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) (NCT07450001) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-03-06 |
| Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation (NCT07561554) | Haisco Pharmaceutical Group Co., Ltd. | 2026-03-06 |
| A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) (NCT07450053) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-03-06 |
| A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007) (NCT07435194) | Merck Sharp & Dohme LLC | 2026-03-06 |
| A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers (NCT07364851) | Daewon Pharmaceutical Co., Ltd. | 2026-03-06 |
| 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT07219147) | City of Hope Medical Center | 2026-03-06 |
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. (NCT07408908) | Xiamen Amoytop Biotech Co., Ltd. | 2026-03-06 |
| A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC (NCT07259213) | Radiopharm Theranostics, Ltd | 2026-03-05 |
| A Study of TPD3310 in Patients With Advanced Malignant Tumors (NCT07368127) | TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. | 2026-03-05 |
| A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants (NCT07462780) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-03-05 |
| Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma (NCT07479732) | Peking University People's Hospital | 2026-03-05 |
| A Study of MK-7240 in Healthy Participants (MK-7240-009) (NCT07405177) | Merck Sharp & Dohme LLC | 2026-03-05 |
| Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction (NCT07406984) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2026-03-05 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry (NCT07335198) | GlaxoSmithKline | 2026-03-05 |
| Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. (NCT07644403) | Suzhou Immunofoco Biotechnology Co., Ltd | 2026-03-05 |
| SKB105 for Injection in Advanced Solid Tumors (NCT07380386) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-03-05 |
| A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection (NCT07411755) | Jiangsu Genscend Biopharmaceutical Co., Ltd | 2026-03-05 |
| A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet (NCT07374224) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-03-05 |
| A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma (NCT07433569) | AstraZeneca | 2026-03-05 |
| Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine) (NCT07691190) | Humanis Saglık Anonim Sirketi | 2026-03-05 |
| A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years (NCT07455825) | AstraZeneca | 2026-03-05 |
| A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis. (NCT07369076) | Nura Bio | 2026-03-04 |
| A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002) (NCT07388667) | Merck Sharp & Dohme LLC | 2026-03-04 |
| A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects (NCT07500181) | Basilea Pharmaceutica | 2026-03-04 |
| A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants (NCT07433179) | Septerna, Inc. | 2026-03-04 |
| The Effect of Losartan on Cephalexin (NCT07300670) | Aleksi Tornio | 2026-03-04 |
| KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study (NCT07462559) | Helsinki University Central Hospital | 2026-03-04 |
| A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors (NCT07277413) | IDEAYA Biosciences | 2026-03-04 |
| A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis (NCT07245992) | Philogen S.p.A. | 2026-03-04 |
| A Food-Effect Study of CX11 in Healthy Participants (NCT07349381) | Vincentage Pharma Co., Ltd | 2026-03-04 |
| HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor (NCT07396584) | Hutchmed | 2026-03-04 |
| Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies (NCT05544968) | Medical College of Wisconsin | 2026-03-04 |
| Study of TGM-312-SC01 in Healthy Participants and Adults With MASH (NCT07427680) | Tangram Therapeutics Plc | 2026-03-03 |
| A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer (NCT07227025) | Janssen Research & Development, LLC | 2026-03-03 |
| Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC (NCT07090148) | University of Wisconsin, Madison | 2026-03-03 |
| A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours (NCT07441707) | Ipsen | 2026-03-03 |
| This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer. (NCT07249879) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-03-03 |
| Radiprodil in Participants With Hepatic Impairment (NCT07457229) | GRIN Therapeutics, Inc. | 2026-03-03 |
| Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation (NCT07453784) | Abivax S.A. | 2026-03-03 |
| A Study of DXC014 in Patients With Advanced Solid Tumors. (NCT07177937) | Hangzhou DAC Biotechnology Co., Ltd. | 2026-03-03 |
| A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector (NCT07413913) | Boehringer Ingelheim | 2026-03-03 |
| Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors (NCT07424547) | Conjupro Biotherapeutics, Inc. | 2026-03-03 |
| A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis (NCT07226895) | Monument Therapeutics Limited | 2026-03-03 |
| Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors (NCT07589530) | Beijing Biotech | 2026-03-02 |
| Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis. (NCT07666815) | Pedro Julian Flores Moreno | 2026-03-02 |
| A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults (NCT07465965) | Shanghai World Leader Pharmaceutical Co., Ltd. | 2026-03-02 |
| Prospective IR-led Sedation Feasibility (NCT07443254) | CAMC Health System | 2026-03-02 |
| Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors (NCT07523529) | Beijing Biotech | 2026-03-02 |
| Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma (NCT07622940) | Beijing Biotech | 2026-03-02 |
| A Study to Evaluate ALN-2232 in Participants With Obesity (NCT07463846) | Alnylam Pharmaceuticals | 2026-03-02 |
| A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases (NCT07357220) | Akeso | 2026-03-02 |
| A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults (NCT07455240) | Pfizer | 2026-03-02 |
| Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events (NCT06863480) | University of Florida | 2026-03-02 |
| Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer (NCT07641036) | Beijing Biotech | 2026-03-02 |
| A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. (NCT07448623) | Novo Nordisk A/S | 2026-03-02 |
| Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer (NCT07589543) | Beijing Biotech | 2026-03-02 |
| Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma (NCT07551336) | Beijing Biotech | 2026-03-02 |
| Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer (NCT07551362) | Beijing Biotech | 2026-03-02 |
| Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas (NCT07319676) | National University Hospital, Singapore | 2026-03-02 |
| Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer (NCT07641049) | Beijing Biotech | 2026-03-02 |
| Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma (NCT07510815) | Beijing Biotech | 2026-03-02 |
| A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia (NCT07615426) | Janssen Research & Development, LLC | 2026-03-02 |
| A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) (NCT07417189) | Abbisko Therapeutics Co, Ltd | 2026-03-02 |